跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 41,142 条关于
“Bell Potter Securities”
全部
41,142
临床试验
34,840
药物
2,634
机构
143
资讯
3,525
4个月前
Paradigm Biopharmaceuticals Secures $14M to Advance Phase 3 Osteoarthritis Trial Through Interim Analysis
去年
Imugene's Azer-Cel Trial Opens First Australian Site; Neuren's Daybue Sales Exceed Expectations
去年
Vertex Pharmaceuticals Faces Securities Fraud Investigation After Disappointing Suzatrigine Trial Results
去年
Invion Doses First Patient in Phase I/II Trial of INV043 for Non-Melanoma Skin Cancer
去年
Serina Therapeutics and enVVeno Medical Each File $100M Mixed Securities Shelf
去年
Iovance CFO Resigns Amid Amtagvi Launch Struggles and Securities Fraud Investigation
去年
Alnylam's Amvuttra Poised to Become First-Line ATTR-CM Treatment
去年
Agios Pharmaceuticals Faces Securities Fraud Investigation Following FDA Delay of PYRUKYND Approval
去年
Click Therapeutics Highlights PDURS Potential to Revolutionize Digital Therapeutics
去年
Cassava Sciences Faces Class Action Lawsuit After Simufilam Fails Phase 3 Trial
第 1 页,共 353 页
上一页
下一页